Drug recall
Red Blood Cells, Leukocytes Reduced, Irradiated
FDA recall event 93182 · Class II · New York Blood Center Enterprises
Key facts
| Event ID | 93182 |
|---|---|
| Recall numbers | B-0009-2024 |
| Recalling firm | New York Blood Center Enterprises |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced, Irradiated |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, collected from a duplicate donor who was previously deferred due to testing human immunodeficiency virus (HIV) reactive, was distributed. |
| Initiation date | Sep 19, 2023 |
| Report date | Nov 1, 2023 |
| Termination date | Oct 20, 2023 |
| City | Long Island City |
| State | NY |
| Country | United States |
| FEI number | 2473015 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: